B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most ...
The company said that ZAMTO Cell is designed to target both CD19 and CD20, which could improve treatment efficacy.
Ten years of substantial work by Université de Montréal immunologist Nathalie Labrecque's team at the Montreal Clinical ...
ZME Science on MSN4d
World’s Oldest Person Had Cells 17 Years Younger Than Her Age. The Surprising Diet and Habits That Helped Her Live to 117When Maria Branyas Morera died in August 2024 at the age of 117, she left behind more than just a legacy as the world’s ...
News Medical on MSN19h
Researchers develop TIM-3 decoy to enhance CAR-T therapy effectiveness for B-ALL tumorsB-cell Acute Lymphoblastic Leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...
Study Finds on MSN8d
When Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
Treatment of B-cell Acute Lymphoblastic Leukaemia has been greatly improved by CAR-T therapies, but relapse is still very common. An international team has now found in animal models a new approach ...
New research shows how a specially trained population of immune cells keeps the peace by preventing other immune cells from attacking their own. The study provides a better understanding of immune ...
Treatment of B-cell Acute Lymphoblastic Leukaemia has improved thanks to CAR-T therapies, but relapse is still very common.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback